Login / Signup

Vaccinomics: a future avenue for vaccine development against emerging pathogens.

José Miguel UrraMarinela Contreras
Published in: Expert review of vaccines (2021)
Vaccines are required for the effective and environmentally sustainable intervention for the control of emerging infectious diseases worldwide. Recent advances in vaccinomics provide a platform to address challenges in improving vaccine efficacy and implementation. As proposed here, quantum vaccinomics will contribute to vaccine development, efficacy, and safety by facilitating antigen combinations to target pathogen infection and transmission in emerging infectious diseases.
Keyphrases
  • infectious diseases
  • randomized controlled trial
  • healthcare
  • primary care
  • high throughput
  • current status
  • candida albicans
  • gram negative
  • multidrug resistant
  • energy transfer
  • quantum dots